
An expert panel reviewed the role of residual retinal fluid in managing neovascular age-related macular degeneration (nAMD). The resulting guidelines emphasize using optical coherence tomography (OCT) to assess fluid status for anti-VEGF treatment decisions. The panel proposed an algorithm for when to administer treatment based on residual fluid, addressing challenges in fluid interpretation and the assumption that any residual fluid indicates ongoing VEGF activity.
Like
Save
Share